Development of Potent and Highly Selective Epoxyketone‐Based Plasmodium Proteasome Inhibitors is a research paper published in Chemistry - A European Journal (2023). On theSindex it has a DataRank of 0.620. It has been cited 25 times, with 11 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.489
From this paper's citation signal
Citation Network Contribution
0.131
From 8 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 11 citers.
Bill and Melinda Gates Foundation
Grant: INV-037899
National Institutes of Health
Grant: R01AI158612
National Institutes of Health
Grant: R21AI133393
National Institutes of Health
Grant: R21AI146387
National Institutes of Health
Grant: R21AI171824
National Institutes of Health
Grant: R01GM061300
St. Baldrick's Foundation
Grant: 940892
National Institutes of Health
Grant: 5R21AI133393-02
Exploring the proteasome as a new drug target to treat schistosomiasis
National Institutes of Health
Grant: 5R21AI146387-02
Selective proteasome inhibitors for trichomoniasis
National Institutes of Health
Grant: 5R01AI158612-05
Proteasome inhibitors against mucosal protozoan pathogens
National Institutes of Health
Grant: 1R21AI171824-01
The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
European Commission
Grant: 846688
Proteasome as a target to combat trichomoniasis
FWCI
5.96
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals